Sign in

CIK 0001158780

  • Non-accelerated filer
  • Smaller reporting company
Ticker
PLUR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
NV
Entity type
Operating
EIN
980351734
Phone
+972 747107171
Business address
MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA, Israel
Former names
PLURISTEM THERAPEUTICS INC, PLURISTEM LIFE SYSTEMS INC, AI SOFTWARE INC
  1. 4 Open-market sale Director sold 2,000 shares at $0.97 ($1,940)
  2. 4 Open-market buy Director bought 80,616 shares at $1.80 ($145,109)
  3. 4 Grant or award Director acquired 20,000 shares (grant or award)
  4. 4 Grant or award Director acquired 20,000 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale 10% owner sold 355,570 shares at an average $3.70 ($1,314,277)
  8. 4 Open-market sale 10% owner sold 410,376 shares at an average $3.86 ($1,584,828)
  9. 4 Open-market sale 10% owner sold 189,725 shares at an average $4.61 ($875,105)
  10. 4 Grant or award Director acquired 20,000 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award Director acquired 20,000 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy 10% owner bought 20,000 shares at $9.70 ($194,000)
  15. 4 Open-market buy 10% owner bought 50,000 shares at an average $9.51 ($475,500)
  16. 4 Open-market buy 10% owner bought 20,000 shares at $9.20 ($184,000)
  17. 4 Open-market buy 10% owner bought 199,129 shares at an average $10.16 ($2,024,123)
  18. 4 Open-market buy 10% owner bought 13,189 shares at $9.49 ($125,164)
  19. 4 Open-market buy 10% owner bought 34,800 shares at $9.02 ($313,896)
  20. 4 Open-market buy 10% owner bought 10,734 shares at an average $9.04 ($96,983)

Page 3 of 18 · 352 filings